Recent studies have demonstrated that Gal3 may serve as a potential biomarker for various renal and cardiovascular conditions, infections, autoimmune diseases, neurodegenerative disorders, and malignancies (Dong et al., 2018; Hara et al., 2020). This evidence concerns the gene LGALS3 and infection.